- Home
- ELDN vs FXNC Comparison
ELDN vs FXNC Comparison
Compare ELDN & FXNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- FXNC
- Stock Information
- Founded
- ELDN 2004
- FXNC 1907
- Country
- ELDN United States
- FXNC United States
- Employees
- ELDN N/A
- FXNC N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- FXNC Major Banks
- Sector
- ELDN Health Care
- FXNC Finance
- Exchange
- ELDN Nasdaq
- FXNC Nasdaq
- Market Cap
- ELDN 178.4M
- FXNC 175.2M
- IPO Year
- ELDN N/A
- FXNC N/A
- Fundamental
- Price
- ELDN $3.06
- FXNC $19.85
- Analyst Decision
- ELDN Strong Buy
- FXNC Strong Buy
- Analyst Count
- ELDN 1
- FXNC 1
- Target Price
- ELDN $16.00
- FXNC $21.00
- AVG Volume (30 Days)
- ELDN 214.2K
- FXNC 16.7K
- Earning Date
- ELDN 05-14-2025
- FXNC 04-30-2025
- Dividend Yield
- ELDN N/A
- FXNC 3.10%
- EPS Growth
- ELDN N/A
- FXNC N/A
- EPS
- ELDN N/A
- FXNC 0.70
- Revenue
- ELDN N/A
- FXNC $64,227,999.00
- Revenue This Year
- ELDN N/A
- FXNC $57.36
- Revenue Next Year
- ELDN N/A
- FXNC $5.03
- P/E Ratio
- ELDN N/A
- FXNC $28.54
- Revenue Growth
- ELDN N/A
- FXNC 31.73
- 52 Week Low
- ELDN $2.30
- FXNC $14.75
- 52 Week High
- ELDN $5.54
- FXNC $26.97
- Technical
- Relative Strength Index (RSI)
- ELDN 49.05
- FXNC 41.64
- Support Level
- ELDN $2.96
- FXNC $20.18
- Resistance Level
- ELDN $3.27
- FXNC $21.18
- Average True Range (ATR)
- ELDN 0.17
- FXNC 0.40
- MACD
- ELDN 0.02
- FXNC -0.05
- Stochastic Oscillator
- ELDN 53.33
- FXNC 0.00
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.